A decision-analytic model of idelalisib in relapsed or refractory patients with indolent non-Hodgkin lymphoma.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W2601575270
